Citadel Advisors’s Chemtura Corporation CHMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-9,200
Closed -$251K 8840
2015
Q4
$251K Buy
9,200
+600
+7% +$17.9K ﹤0.01% 5491
2015
Q3
$246K Sell
8,600
-5,300
-38% -$145K ﹤0.01% 5854
2015
Q2
$394K Buy
13,900
+5,900
+74% +$174K ﹤0.01% 5342
2015
Q1
$218K Sell
8,000
-6,000
-43% -$148K ﹤0.01% 6080
2014
Q4
$346K Buy
14,000
+300
+2% +$6.97K ﹤0.01% 5227
2014
Q3
$320K Sell
13,700
-2,200
-14% -$54.5K ﹤0.01% 5193
2014
Q2
$415K Buy
15,900
+13,600
+591% +$335K ﹤0.01% 4646
2014
Q1
$58K Buy
2,300
+2,200
+2,200% +$56.1K ﹤0.01% 6658
2013
Q4
$3K Buy
+100
New +$2.5K ﹤0.01% 6884
2013
Q3
Sell
-4,600
Closed -$93K 6992
2013
Q2
$93K Buy
+4,600
New +$99.6K ﹤0.01% 5281

Citadel Advisors's CHMT Position: Q2 2017 in Review

Citadel Advisors sold out of Chemtura Corporation (CHMT) in Q2 2017, closing a stake of 13,782 shares — an estimated $460K sold.

Citadel Advisors first reported a position in CHMT in Q2 2013 and held it in 12 quarters. The position peaked at $6.97M in Q2 2013. 0 funds tracked by Wall St. Rank hold CHMT as of Q2 2017.

  • Citadel Advisors reported no remaining Chemtura Corporation position as of Q2 2017 after selling out during the quarter.
  • Citadel Advisors sold 13,782 Chemtura Corporation shares in Q2 2017, an estimated $460K.
  • Citadel Advisors first reported a position in Chemtura Corporation in Q2 2013 and held it in 12 quarters.
  • Citadel Advisors's Chemtura Corporation position peaked at $6.97M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held Chemtura Corporation as of Q2 2017.

Based on Citadel Advisors's 13F filing for Q2 2017, filed 11 Aug 2017.